IFNB1 and myeloid sarcoma: Also encouraging were the experiments of Jacobs et al who reported that multiple sclerosis (MS) patients, treated with partially purified human IFN-β administered by lumbar puncture had a significant decrease in the frequency of the periodic exacerbations characteristic of that disease [11].